Tarnagulla Ventures
Venture capitalSouth Yarra · Pre-Seed–Series A · 2 people tracked
Investment thesis
Tarnagulla Ventures backs innovative companies developing potentially life-changing products, with a portfolio concentrated in biopharmaceutical and life sciences ventures. Its investments target novel therapies for conditions such as dry eye, osteoarthritis, retinal diseases, rare single-gene disorders, metabolic disorders, CNS conditions, autoimmune and inflammatory diseases, and maternal/infant health via probiotics.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from the firm's websiteCo-manages the family-owned firm Tarnagulla Ventures.
Co-manages the family-owned firm Tarnagulla Ventures.
Investments · 7 tracked
founders shown can be your intro pathClinical-stage biopharmaceutical company developing small molecule new chemical entities for autoimmune and inflammatory diseases.
Develops peripherally-restricted CB1 receptor inverse agonists for Prader-Willi syndrome, type 1 diabetes and metabolic disorders.
Clinical-stage specialty pharmaceutical company developing therapies for rare single-gene-deficiency diseases, including its JOTROL formulation of Resveratrol.
Development-stage life sciences company commercializing improved versions of CNS treatments not previously marketed in the US.
Biopharmaceutical company in Weston, Massachusetts developing recombinant human lubricant to treat dry eye, osteoarthritis and other age- and inflammation-related conditions.
Biopharmaceutical company developing NACA, a small molecule antioxidant for treating retinitis pigmentosa and other retinal diseases.
Develops science-based probiotic biotherapeutics to support maternal microbiome health during pregnancy and reduce infant food allergy risk.
Frequently asked questions
- What stage does Tarnagulla Ventures invest at?
- Tarnagulla Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Tarnagulla Ventures focus on?
- Tarnagulla Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Tarnagulla Ventures located?
- Tarnagulla Ventures is headquartered in South Yarra, AU.
Similar investors
Amadeus Capital Partners is a technology investor. It held a first close of $75M on its Amadeus IV Digital Prosperity Fund, focused on late-stage venture and growth companies building online and mobile services for emerging-market middle classes.
B Capital Group is a multistage venture capital firm that invests from seed to late stage, offering value-added support to founders in partnership with management consulting firm BCG.
Breyer Capital is a venture capital firm founded and led by Jim Breyer, headquartered in Austin, Texas, focused on long-term entrepreneurs in AI, quantum technology, and computation-driven healthcare and life sciences.
DCVC (Data Collective) is a deep tech venture capital firm backing entrepreneurs using computational approaches to solve large real-world problems across many industries. It operates six flagship funds plus DCVC Bio, spanning 13 funds to date.
Excell Partners manages a state-supported fund in partnership with the University of Rochester and New York State, offering pre-seed and seed stage capital to early-stage technology companies in Upstate New York.